NYSE:EVH - Evolent Health Stock Price, Price Target & More

$16.55 +0.15 (+0.91 %)
(As of 04/26/2018 05:24 AM ET)
Previous Close$16.40
Today's Range$16.20 - $16.75
52-Week Range$10.30 - $27.50
Volume875,000 shs
Average Volume847,101 shs
Market Capitalization$1.27 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.07

About Evolent Health (NYSE:EVH)

Evolent Health logoEvolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management. Its services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services, and comprehensive health plan administration services. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Receive EVH News and Ratings via Email

Sign-up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Management services
Sub-IndustryN/A
SectorComputer and Technology
SymbolNYSE:EVH
CUSIPN/A
Phone571-389-6000

Debt

Debt-to-Equity Ratio0.12%
Current Ratio2.85%
Quick Ratio2.85%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$434.95 million
Price / Sales2.95
Cash FlowN/A
Price / CashN/A
Book Value$13.52 per share
Price / Book1.22

Profitability

EPS (Most Recent Fiscal Year)($0.70)
Net Income$-60,660,000.00
Net Margins-14.05%
Return on Equity-3.51%
Return on Assets-2.79%

Miscellaneous

Employees2,600
Outstanding Shares77,440,000

How to Become a New Pot Stock Millionaire

Evolent Health (NYSE:EVH) Frequently Asked Questions

What is Evolent Health's stock symbol?

Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."

How were Evolent Health's earnings last quarter?

Evolent Health (NYSE:EVH) issued its quarterly earnings results on Tuesday, February, 27th. The technology company reported ($0.10) EPS for the quarter, meeting analysts' consensus estimates of ($0.10). The technology company had revenue of $113.97 million for the quarter, compared to analyst estimates of $111.09 million. Evolent Health had a negative return on equity of 3.51% and a negative net margin of 14.05%. View Evolent Health's Earnings History.

What price target have analysts set for EVH?

12 Wall Street analysts have issued twelve-month price objectives for Evolent Health's shares. Their forecasts range from $20.00 to $30.00. On average, they expect Evolent Health's share price to reach $25.3333 in the next twelve months. View Analyst Ratings for Evolent Health.

What are Wall Street analysts saying about Evolent Health stock?

Here are some recent quotes from research analysts about Evolent Health stock:
  • 1. According to Zacks Investment Research, "Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. " (3/8/2018)
  • 2. Cantor Fitzgerald analysts commented, "Health plan acquisitions. Over the past few months, EVH has announced two small health plan acquisitions that should help to grow its platform and operations revenue and add a new line of business. The acquisition of Premier in Dayton, OH, is somewhat more concerning for investors as the regulatory filings show that the plan is in a loss position. However, many provider-owned health plans typically show losses in regulatory filings. The company is expecting to receive better pricing from Premier and that it is not considering additional health plan acquisitions, at least in the near term. However, it will continue to use capital to align the company with customers. Note, our estimates do not yet reflect the health plan acquisitions." (12/3/2017)

Who are some of Evolent Health's key competitors?

Who are Evolent Health's key executives?

Evolent Health's management team includes the folowing people:
  • Mr. Frank J. Williams, Co-Founder, CEO & Director (Age 51)
  • Mr. Seth Blackley, Co-Founder & Pres (Age 39)
  • Mr. Steven J. Wigginton, Former Exec. VP (Age 52)
  • Mr. Tom Peterson III, Co-Founder & COO (Age 48)
  • Mr. Nicholas McGrane, Chief Financial Officer (Age 50)

When did Evolent Health IPO?

(EVH) raised $150 million in an IPO on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs acted as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

Has Evolent Health been receiving favorable news coverage?

News headlines about EVH stock have trended somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies positive and negative news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Evolent Health earned a news sentiment score of 0.20 on Accern's scale. They also assigned news stories about the technology company an impact score of 45.74 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

How do I buy shares of Evolent Health?

Shares of EVH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Evolent Health's stock price today?

One share of EVH stock can currently be purchased for approximately $16.55.

How big of a company is Evolent Health?

Evolent Health has a market capitalization of $1.27 billion and generates $434.95 million in revenue each year. The technology company earns $-60,660,000.00 in net income (profit) each year or ($0.70) on an earnings per share basis. Evolent Health employs 2,600 workers across the globe.

How can I contact Evolent Health?

Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The technology company can be reached via phone at 571-389-6000.


MarketBeat Community Rating for Evolent Health (EVH)

Community Ranking:  3.5 out of 5 (star star star half star)
Outperform Votes:  302 (Vote Outperform)
Underperform Votes:  134 (Vote Underperform)
Total Votes:  436
MarketBeat's community ratings are surveys of what our community members think about Evolent Health and other stocks. Vote "Outperform" if you believe EVH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EVH will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Evolent Health (NYSE:EVH) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
12 Wall Street analysts have issued ratings and price targets for Evolent Health in the last 12 months. Their average twelve-month price target is $25.3333, suggesting that the stock has a possible upside of 53.07%. The high price target for EVH is $30.00 and the low price target for EVH is $20.00. There are currently 12 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.08
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
12 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $25.3333$25.3333$28.00$28.4545
Price Target Upside: 53.07% upside72.92% upside108.96% upside56.77% upside

Evolent Health (NYSE:EVH) Consensus Price Target History

Price Target History for Evolent Health (NYSE:EVH)

Evolent Health (NYSE:EVH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/28/2018Canaccord GenuityLower Price TargetBuy -> Buy$27.00 -> $24.00HighView Rating Details
2/28/2018Wells FargoLower Price TargetOutperform$27.00 -> $20.00LowView Rating Details
2/13/2018Jefferies GroupSet Price TargetBuy$22.00LowView Rating Details
1/4/2018CitigroupInitiated CoverageBuyHighView Rating Details
12/3/2017Cantor FitzgeraldReiterated RatingBuy$30.00LowView Rating Details
11/18/2017Leerink SwannSet Price TargetBuy$25.00N/AView Rating Details
11/7/2017Goldman SachsDowngradeConviction-Buy -> BuyN/AView Rating Details
11/3/2017SunTrust BanksReiterated RatingBuy$30.00N/AView Rating Details
11/1/2017Robert W. BairdReiterated RatingBuy$25.00N/AView Rating Details
10/6/2017CowenReiterated RatingOutperform$33.00 -> $29.00N/AView Rating Details
9/19/2017KeyCorpInitiated CoverageOverweight -> Overweight$23.00LowView Rating Details
8/18/2017JPMorgan ChaseReiterated RatingBuyLowView Rating Details
3/14/2017CIBCInitiated CoverageOutperform -> OutperformLowView Rating Details
3/13/2017OppenheimerInitiated CoverageOutperform$28.00LowView Rating Details
9/30/2016William BlairReiterated RatingOutperformN/AView Rating Details
8/5/2016FBR & CoBoost Price TargetOutperform$24.00 -> $26.00N/AView Rating Details
(Data available from 4/26/2016 forward)

Earnings

Evolent Health (NYSE:EVH) Earnings History and Estimates Chart

Earnings by Quarter for Evolent Health (NYSE:EVH)

Evolent Health (NYSE:EVH) Earnings Estimates

2018 EPS Consensus Estimate: ($0.05)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20185($0.05)($0.02)($0.03)
Q2 20184($0.02)$0.01($0.01)
Q3 20184($0.01)($0.01)($0.01)
Q4 20184($0.01)$0.01($0.01)

Evolent Health (NYSE EVH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/27/2018Q4 2017($0.10)($0.10)$111.09 million$113.97 millionViewN/AView Earnings Details
11/2/2017Q3 2017($0.08)($0.04)$104.49 million$107.90 millionViewN/AView Earnings Details
8/7/2017Q2 2017($0.13)($0.13)$104.45 million$107.30 millionViewListenView Earnings Details
5/9/2017Q1 2017($0.15)($0.26)$104.38 million$106.80 millionViewListenView Earnings Details
2/28/2017Q416($0.20)($0.35)$84.98 million$88.00 millionViewListenView Earnings Details
11/9/2016Q316($0.13)($0.26)$58.35 million$60.20 millionViewListenView Earnings Details
8/4/2016Q216($0.16)($0.12)$51.96 million$56.50 millionViewN/AView Earnings Details
5/12/2016Q116($0.19)($0.16)$47.40 million$49.50 millionViewListenView Earnings Details
2/25/2016Q415($0.21)($0.05)$43.73 million$46.70 millionViewListenView Earnings Details
11/5/2015Q315($0.21)($0.16)$42.51 million$43.30 millionViewN/AView Earnings Details
8/6/2015Q215($0.37)($1.00)$157.50 million$36.50 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Evolent Health (NYSE:EVH) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Evolent Health (NYSE EVH) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 8.79%
Institutional Ownership Percentage: 99.71%
Insider Trading History for Evolent Health (NYSE:EVH)
Institutional Ownership by Quarter for Evolent Health (NYSE:EVH)

Evolent Health (NYSE EVH) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/1/2018Unitedhealth Group IncDirectorSell3,040,000$13.70$41,648,000.00View SEC Filing  
8/3/2017Frank J. WilliamsCEOSell16,300$23.73$386,799.00View SEC Filing  
8/1/2017Steve WiggintonCEOSell6,000$24.64$147,840.00View SEC Filing  
7/24/2017Thomas Peterson IIICOOSell40,540$26.00$1,054,040.00View SEC Filing  
7/10/2017Nicholas McgraneCFOSell1,667$25.42$42,375.14View SEC Filing  
7/6/2017Frank J. WilliamsCEOSell16,300$24.76$403,588.00View SEC Filing  
7/3/2017Steve WiggintonCEOSell6,000$25.07$150,420.00View SEC Filing  
6/28/2017Tpg Growth Ii Advisors, Inc.InsiderSell4,279,325$25.87$110,706,137.75View SEC Filing  
6/15/2017Seth BlackleyPresidentSell15,000$25.22$378,300.00View SEC Filing  
6/12/2017Nicholas McgraneCFOSell1,667$24.58$40,974.86View SEC Filing  
6/7/2017Nicholas McgraneCFOSell10,495$26.95$282,840.25View SEC Filing  
6/6/2017Kenneth A. SametDirectorSell4,000$25.75$103,000.00View SEC Filing  
6/6/2017Steve WiggintonCEOSell959$25.75$24,694.25View SEC Filing  
5/19/2017Cheryl ScottDirectorSell5,477$23.51$128,764.27View SEC Filing  
5/19/2017Frank J. WilliamsCEOSell114,865$24.30$2,791,219.50View SEC Filing  
5/19/2017Jonathan WeinbergGeneral CounselSell17,230$24.30$418,689.00View SEC Filing  
5/19/2017Nicholas McgraneCFOSell47,508$24.30$1,154,444.40View SEC Filing  
5/19/2017Thomas Peterson IIICOOSell57,433$24.30$1,395,621.90View SEC Filing  
5/19/2017Tpg Growth Ii Advisors, Inc.InsiderSell3,081,760$24.30$74,886,768.00View SEC Filing  
5/19/2017UpmcMajor ShareholderSell2,333,333$24.30$56,699,991.906,434,283View SEC Filing  
5/15/2017Seth BlackleyPresidentSell15,000$25.00$375,000.00760,944View SEC Filing  
5/15/2017Thomas Peterson IIICOOSell83,108$24.99$2,076,868.92341,092View SEC Filing  
5/10/2017Nicholas McgraneInsiderSell1,667$24.28$40,474.76132,047View SEC Filing  
5/10/2017Thomas Peterson IIICOOSell18,604$25.00$465,100.00395,587View SEC Filing  
5/4/2017Frank J WilliamsCEOSell16,300$23.55$383,865.001,284,943View SEC Filing  
5/3/2017Jonathan WeinbergGeneral CounselSell15,000$23.85$357,750.0086,385View SEC Filing  
5/1/2017Steve WiggintonCEOSell6,000$23.10$138,600.00364,704View SEC Filing  
5/1/2017UpmcMajor ShareholderSell403,644$19.53$7,883,167.328,767,616View SEC Filing  
4/19/2017Nicholas McgraneCFOSell1,667$22.52$37,540.84132,047View SEC Filing  
4/17/2017Seth BlackleyPresidentSell15,000$21.48$322,200.00794,602View SEC Filing  
4/6/2017Frank J WilliamsCEOSell16,300$22.03$359,089.001,301,243View SEC Filing  
4/3/2017Steve WiggintonCEOSell6,000$23.15$138,900.00364,704View SEC Filing  
3/31/2017UpmcMajor ShareholderSell2,690,961$19.53$52,554,468.339,171,260View SEC Filing  
3/30/2017Seth BlackleyPresidentSell15,000$21.19$317,850.00807,228View SEC Filing  
3/28/2017Board Co AdvisoryMajor ShareholderSell2,118,078$19.53$41,366,063.346,246,245View SEC Filing  
3/24/2017Nicholas McgraneCFOSell7,034$22.50$158,265.00137,414View SEC Filing  
1/30/2017Seth BlackleyPresidentSell15,000$17.58$263,700.00824,848View SEC Filing  
1/17/2017Seth BlackleyPresidentSell30,000$17.98$539,400.00854,848View SEC Filing  
11/14/2016Michael D'amatoDirectorBuy10,000$17.18$171,800.0018,183View SEC Filing  
9/22/2016Board Co AdvisoryMajor ShareholderSell317,712$22.50$7,148,520.004,128,167View SEC Filing  
9/14/2016Board Co AdvisoryMajor ShareholderSell1,936,529$22.50$43,571,902.504,445,879View SEC Filing  
9/14/2016Chad PomeroyInsiderSell55,180$21.54$1,188,577.20286,370View SEC Filing  
9/14/2016Frank J WilliamsCEOSell251,481$21.54$5,416,900.741,304,799View SEC Filing  
9/14/2016Jonathan WeinbergGeneral CounselSell10,339$21.54$222,702.0676,245View SEC Filing  
9/14/2016Nicholas McgraneCFOSell21,205$21.54$456,755.70136,495View SEC Filing  
9/14/2016Seth BlackleyPresidentSell167,672$21.54$3,611,654.88869,848View SEC Filing  
9/14/2016Thomas Peterson IIICOOSell72,827$21.54$1,568,693.58377,623View SEC Filing  
6/10/2015Gary PieferInsiderBuy2,000$17.00$34,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Evolent Health (NYSE EVH) News Headlines

Source:
DateHeadline
JPMorgan Assumes Evolent Health (EVH) at NeutralJPMorgan Assumes Evolent Health (EVH) at Neutral
www.streetinsider.com - April 25 at 10:29 AM
Evolent Health (EVH) Downgraded by JPMorgan ChaseEvolent Health (EVH) Downgraded by JPMorgan Chase
www.americanbankingnews.com - April 24 at 8:28 AM
Evolent Health, Inc. to Release First Quarter 2018 Operating Results and Host Conference Call on Wednesday, May 9, 2018Evolent Health, Inc. to Release First Quarter 2018 Operating Results and Host Conference Call on Wednesday, May 9, 2018
finance.yahoo.com - April 23 at 4:00 PM
Evolent Health (EVH) Downgraded by BidaskClub to "Buy"Evolent Health (EVH) Downgraded by BidaskClub to "Buy"
www.americanbankingnews.com - April 16 at 10:25 AM
Evolent Health (EVH) Cut to "Sell" at ValuEngineEvolent Health (EVH) Cut to "Sell" at ValuEngine
www.americanbankingnews.com - April 15 at 10:59 AM
BidaskClub Lowers Evolent Health (EVH) to HoldBidaskClub Lowers Evolent Health (EVH) to Hold
www.americanbankingnews.com - April 14 at 11:25 PM
ServiceMaster (SERV) and Evolent Health (EVH) Critical SurveyServiceMaster (SERV) and Evolent Health (EVH) Critical Survey
www.americanbankingnews.com - April 13 at 1:18 PM
Evolent Health (EVH) Receives Consensus Recommendation of "Buy" from AnalystsEvolent Health (EVH) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - April 12 at 9:53 AM
Evolent Health (EVH) Earns Outperform Rating from CowenEvolent Health (EVH) Earns Outperform Rating from Cowen
www.americanbankingnews.com - April 11 at 6:13 PM
Somatus Raises $11 Million in Series B FinancingSomatus Raises $11 Million in Series B Financing
www.prnewswire.com - April 11 at 10:47 AM
$140.96 Million in Sales Expected for Evolent Health (EVH) This Quarter$140.96 Million in Sales Expected for Evolent Health (EVH) This Quarter
www.americanbankingnews.com - April 11 at 2:05 AM
Evolent Health (EVH) Expected to Post Earnings of -$0.04 Per ShareEvolent Health (EVH) Expected to Post Earnings of -$0.04 Per Share
www.americanbankingnews.com - April 9 at 7:19 PM
Contrasting Evolent Health (EVH) & FranklinCovey (FC)Contrasting Evolent Health (EVH) & FranklinCovey (FC)
www.americanbankingnews.com - April 7 at 1:25 PM
ValuEngine Lowers Evolent Health (EVH) to Strong SellValuEngine Lowers Evolent Health (EVH) to Strong Sell
www.americanbankingnews.com - April 3 at 4:16 PM
Evolent Health (EVH) Downgraded by Goldman Sachs to BuyEvolent Health (EVH) Downgraded by Goldman Sachs to Buy
www.americanbankingnews.com - April 1 at 4:16 PM
Evolent Health (EVH) Receives New Coverage from Analysts at CitigroupEvolent Health (EVH) Receives New Coverage from Analysts at Citigroup
www.americanbankingnews.com - March 30 at 4:32 PM
Head-To-Head Survey: Evolent Health (EVH) & QuinStreet (QNST)Head-To-Head Survey: Evolent Health (EVH) & QuinStreet (QNST)
www.americanbankingnews.com - March 26 at 5:28 AM
Evolent Health Inc (EVH) Expected to Announce Quarterly Sales of $140.96 MillionEvolent Health Inc (EVH) Expected to Announce Quarterly Sales of $140.96 Million
www.americanbankingnews.com - March 25 at 2:52 AM
 Analysts Expect Evolent Health Inc (EVH) to Announce -$0.04 Earnings Per Share Analysts Expect Evolent Health Inc (EVH) to Announce -$0.04 Earnings Per Share
www.americanbankingnews.com - March 23 at 7:26 PM
NQ Mobile (LKM) vs. Evolent Health (EVH) Financial AnalysisNQ Mobile (LKM) vs. Evolent Health (EVH) Financial Analysis
www.americanbankingnews.com - March 21 at 9:12 PM
Evolent Health Supports Ten ACOs Accepted to Next Generation ACO Program for 2018 Performance YearEvolent Health Supports Ten ACOs Accepted to Next Generation ACO Program for 2018 Performance Year
finance.yahoo.com - March 20 at 4:11 PM
Evolent Health Inc (EVH) Receives Consensus Rating of "Buy" from BrokeragesEvolent Health Inc (EVH) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - March 18 at 10:20 AM
Evolent Health (EVH) Downgraded by Zacks Investment ResearchEvolent Health (EVH) Downgraded by Zacks Investment Research
www.americanbankingnews.com - March 8 at 9:58 PM
Zacks: Brokerages Anticipate Evolent Health Inc (EVH) Will Announce Quarterly Sales of $140.94 MillionZacks: Brokerages Anticipate Evolent Health Inc (EVH) Will Announce Quarterly Sales of $140.94 Million
www.americanbankingnews.com - March 8 at 3:48 AM
Evolent Health Inc (EVH) Director Sells $41,648,000.00 in StockEvolent Health Inc (EVH) Director Sells $41,648,000.00 in Stock
www.americanbankingnews.com - March 5 at 6:22 PM
Evolent Health Inc (EVH) Stake Decreased by Sectoral Asset Management IncEvolent Health Inc (EVH) Stake Decreased by Sectoral Asset Management Inc
www.americanbankingnews.com - March 5 at 4:06 PM
State of Wisconsin Investment Board Buys Shares of 400,000 Evolent Health Inc (EVH)State of Wisconsin Investment Board Buys Shares of 400,000 Evolent Health Inc (EVH)
www.americanbankingnews.com - March 2 at 7:50 PM
Lombard Odier Asset Management USA Corp Has $4.67 Million Position in Evolent Health Inc (EVH)Lombard Odier Asset Management USA Corp Has $4.67 Million Position in Evolent Health Inc (EVH)
www.americanbankingnews.com - March 2 at 6:16 PM
Cortina Asset Management LLC Buys 125,053 Shares of Evolent Health Inc (EVH)Cortina Asset Management LLC Buys 125,053 Shares of Evolent Health Inc (EVH)
www.americanbankingnews.com - March 2 at 1:32 PM
Standard Life Aberdeen plc Buys New Holdings in Evolent Health Inc (EVH)Standard Life Aberdeen plc Buys New Holdings in Evolent Health Inc (EVH)
www.americanbankingnews.com - March 1 at 6:50 PM
Carillon Tower Advisers Inc. Acquires Shares of 945,560 Evolent Health Inc (EVH)Carillon Tower Advisers Inc. Acquires Shares of 945,560 Evolent Health Inc (EVH)
www.americanbankingnews.com - March 1 at 5:40 AM
Canaccord Genuity Lowers Evolent Health (EVH) Price Target to $24.00Canaccord Genuity Lowers Evolent Health (EVH) Price Target to $24.00
www.americanbankingnews.com - February 28 at 5:52 PM
Evolent Health (EVH) PT Lowered to $20.00Evolent Health (EVH) PT Lowered to $20.00
www.americanbankingnews.com - February 28 at 4:12 PM
Evolent Health Announces Fourth Quarter and Full Year 2017 Results - PR Newswire (press release)Evolent Health Announces Fourth Quarter and Full Year 2017 Results - PR Newswire (press release)
www.prnewswire.com - February 28 at 4:10 PM
Evolent Health Announces Fourth Quarter and Full Year 2017 ResultsEvolent Health Announces Fourth Quarter and Full Year 2017 Results
finance.yahoo.com - February 28 at 10:31 AM
Evolent Health Inc (EVH) Given Average Rating of "Buy" by BrokeragesEvolent Health Inc (EVH) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - February 21 at 12:37 PM
-$0.04 EPS Expected for Evolent Health Inc (EVH) This Quarter-$0.04 EPS Expected for Evolent Health Inc (EVH) This Quarter
www.americanbankingnews.com - February 17 at 11:16 PM
Jefferies Group Comments on Evolent Health Incs FY2017 Earnings (EVH)Jefferies Group Comments on Evolent Health Inc's FY2017 Earnings (EVH)
www.americanbankingnews.com - February 15 at 7:56 AM
Jefferies Group Analysts Give Evolent Health (EVH) a $22.00 Price TargetJefferies Group Analysts Give Evolent Health (EVH) a $22.00 Price Target
www.americanbankingnews.com - February 13 at 3:10 PM
Evolent Health, Inc. to Release Fourth Quarter and Full Year 2017 ... - PR Newswire (press release)Evolent Health, Inc. to Release Fourth Quarter and Full Year 2017 ... - PR Newswire (press release)
www.prnewswire.com - February 9 at 3:26 PM
Evolent Health, Inc. to Release Fourth Quarter and Full Year 2017 Operating Results and Host Conference Call on Tuesday, February 27, 2018Evolent Health, Inc. to Release Fourth Quarter and Full Year 2017 Operating Results and Host Conference Call on Tuesday, February 27, 2018
finance.yahoo.com - February 9 at 3:26 PM
Evolent Health Inc (EVH) Given Consensus Rating of "Buy" by AnalystsEvolent Health Inc (EVH) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - January 27 at 10:58 AM
William Blair Comments on Evolent Health Incs FY2019 Earnings (EVH)William Blair Comments on Evolent Health Inc's FY2019 Earnings (EVH)
www.americanbankingnews.com - January 15 at 3:44 PM
KeyCorp Comments on Evolent Health Incs Q1 2018 Earnings (EVH)KeyCorp Comments on Evolent Health Inc's Q1 2018 Earnings (EVH)
www.americanbankingnews.com - January 15 at 5:38 AM
Evolent Health Inc to Post Q4 2018 Earnings of ($0.01) Per Share, KeyCorp Forecasts (EVH)Evolent Health Inc to Post Q4 2018 Earnings of ($0.01) Per Share, KeyCorp Forecasts (EVH)
www.americanbankingnews.com - January 12 at 8:02 PM
Brokers Offer Predictions for Evolent Health Incs FY2017 Earnings (EVH)Brokers Offer Predictions for Evolent Health Inc's FY2017 Earnings (EVH)
www.americanbankingnews.com - January 8 at 2:28 AM
Evolent Health Inc Forecasted to Post Q3 2018 Earnings of ($0.01) Per Share (EVH)Evolent Health Inc Forecasted to Post Q3 2018 Earnings of ($0.01) Per Share (EVH)
www.americanbankingnews.com - January 5 at 12:32 PM
Evolent Health Sees Unusually Large Options Volume (EVH)Evolent Health Sees Unusually Large Options Volume (EVH)
www.americanbankingnews.com - January 5 at 2:10 AM
Complete Genomics (GNOM) & Evolent Health (EVH) Financial ComparisonComplete Genomics (GNOM) & Evolent Health (EVH) Financial Comparison
www.americanbankingnews.com - January 4 at 5:04 PM
Evolent Health Completes Acquisition of Assets from New Mexico ... - PR Newswire (press release)Evolent Health Completes Acquisition of Assets from New Mexico ... - PR Newswire (press release)
www.prnewswire.com - January 2 at 11:27 PM

SEC Filings

Evolent Health (NYSE:EVH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Evolent Health (NYSE:EVH) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Evolent Health (NYSE EVH) Stock Chart for Thursday, April, 26, 2018

Loading chart…

This page was last updated on 4/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.